These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25420744)

  • 41. Harmonization of evidence requirements for health technology assessment in reimbursement decision making.
    Hutton J; Trueman P; Facey K
    Int J Technol Assess Health Care; 2008; 24(4):511-7. PubMed ID: 18828948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective.
    Xie F; Bowen JM; Sutherland SC; Burke N; Blackhouse G; Tarride JE; O'Reilly D; Goeree R
    Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):513-21. PubMed ID: 21958096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Economic evaluation guidelines in Latin America: a current snapshot.
    Augustovski F; Garay OU; Pichon-Riviere A; Rubinstein A; Caporale JE
    Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):525-37. PubMed ID: 20950069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Co-ordinating health technology assessment in Canada: a European perspective.
    McDaid D
    Health Policy; 2003 Feb; 63(2):205-13. PubMed ID: 12543533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integration of health technology assessment recommendations into organizational and clinical practice: A case study in Catalonia.
    Gagnon MP; Sánchez E; Pons JM
    Int J Technol Assess Health Care; 2006; 22(2):169-76. PubMed ID: 16571192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health Technology Assessment Implementation in Ukraine: Current Status and Future Perspectives.
    Csanádi M; Inotai A; Oleshchuk O; Lebega O; Alexandra B; Piniazhko O; Németh B; Kaló Z
    Int J Technol Assess Health Care; 2019; 35(5):393-400. PubMed ID: 31583985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Historical development of health technology assessment in Thailand.
    Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden.
    Schwarzer R; Siebert U
    Int J Technol Assess Health Care; 2009 Jul; 25(3):305-14. PubMed ID: 19619349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Health technology assessment in Denmark: strategy, implementation, and developments.
    Sigmund H; Kristensen FB
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():94-101. PubMed ID: 19505351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mental health policy developments in Latin America.
    Alarcón RD; Aguilar-Gaxiola SA
    Bull World Health Organ; 2000; 78(4):483-90. PubMed ID: 10885167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resource allocation and health technology assessment in Australia: views from the local level.
    Gallego G; van Gool K; Kelleher D
    Int J Technol Assess Health Care; 2009 Apr; 25(2):134-40. PubMed ID: 19331706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The uses of modern technologies: problems and perspectives for industrialized and developing countries.
    Banta D
    Bull Pan Am Health Organ; 1984; 18(2):139-50. PubMed ID: 6487871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of health technology assessment in shaping the benefits package in The Netherlands.
    Stolk EA; de Bont A; van Halteren AR; Bijlmer RJ; Poley MJ
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):85-94. PubMed ID: 19371181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Foundations for the institutionalization of health technology assessment in Chile].
    Castillo-Riquelme M; Santelices C E
    Rev Med Chil; 2014 Jan; 142 Suppl 1():S50-4. PubMed ID: 24861181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Developing a decision support system to link health technology assessment (HTA) reports to the health system policies in Iran.
    Yazdani S; Jadidfard MP
    Health Policy Plan; 2017 May; 32(4):504-515. PubMed ID: 28025325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determinants of knowledge translation from health technology assessment to policy-making in China: From the perspective of researchers.
    Liu W; Shi L; Pong RW; Dong H; Mao Y; Tang M; Chen Y
    PLoS One; 2018; 13(1):e0190732. PubMed ID: 29300753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HEALTH TECHNOLOGY ASSESSMENT IN TURKEY.
    Kahveci R; Koç EM; Küçük EÖ
    Int J Technol Assess Health Care; 2017 Jan; 33(3):402-408. PubMed ID: 28595660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Social and ethical analysis in health technology assessment.
    Tantivess S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S81-6. PubMed ID: 24964703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.